Provided by Tiger Trade Technology Pte. Ltd.

Illumina

206.45
+5.182.57%
Post-market: 207.180.7300+0.35%19:55 EDT
Volume:2.41M
Turnover:498.05M
Market Cap:31.17B
PE:38.44
High:208.39
Open:201.81
Low:200.01
Close:201.27
52wk High:231.81
52wk Low:88.00
Shares:151.00M
Float Shares:149.05M
Volume Ratio:1.46
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.37
EPS(LYR):5.45
ROE:32.34%
ROA:8.67%
PB:10.98
PE(LYR):37.88

Loading ...

Illumina (ILMN) Is Up 5.7% After Raising 2026 Revenue Guidance and Q3 Outlook

Simply Wall St.
·
Aug 02

Illumina (ILMN) Stock Climbs On Clinical Growth Despite Margin Pressure

Simply Wall St.
·
Aug 01

LIVE Markets-us Earnings Forecast Jumps Further After Key Reports This Week

Reuters
·
Aug 01

Stryker Corp Stock (SYK) Moved Down by 6.58% on Jul 31: What Investors Need To Know

TradingKey
·
Aug 01

A Spot is Opening up in the S&P 500, and These Stocks are Top Candidates to Fill the Void

Dow Jones
·
Jul 31

Movement Alert|Illumina Falls 5.52% in Regular Trading, Stock Reverses Sharply Despite Q2 Earnings Beat and Price Target Upgrade

Market Focus
·
Jul 31

Illumina is Maintained at Buy by Guggenheim

Dow Jones
·
Jul 31

RBC Raises Price Target on Illumina to $230 From $170, Keeps Outperform Rating

MT Newswires Live
·
Jul 31

Illumina price target raised to $215 from $185 at Bernstein

TIPRANKS
·
Jul 31

Illumina Inc : TD Cowen Raises Target Price to $210 from $192

THOMSON REUTERS
·
Jul 31

Illumina price target raised to $226 from $200 at Guggenheim

TIPRANKS
·
Jul 31

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alignment Healthcare (ALHC), Illumina (ILMN) and Siemens Healthineers AG (OtherSEMHF)

TIPRANKS
·
Jul 31

Illumina Inc : JP Morgan Raises Target Price to $230 from $220

THOMSON REUTERS
·
Jul 31

Illumina Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Illumina Inc : Jefferies Raises Target Price to $185 from $150

THOMSON REUTERS
·
Jul 31

Illumina Inc : Leerink Partners Raises Target Price to $220.00 from $210.00

THOMSON REUTERS
·
Jul 31

Illumina Q2 2026 Revenue Growth Accelerates on Rising Clinical Demand, Strong NovaSeq X Placements, Company Says

Reuters
·
Jul 31

Stock Track | Illumina Plunges 6.14% in After-Hours Despite Q2 Beat and Raised Guidance, as Elevated Valuation and GAAP EPS Decline Spook Investors

Stock Track
·
Jul 31

Illumina Raises Outlook as Sequencing Demand Lifts 2Q Sales

Dow Jones
·
Jul 31

Illumina Fiscal Q2 Earnings, Revenue Rise; 2026 Guidance Revised

MT Newswires Live
·
Jul 31